- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT00970372
Dual-Diagnosis and Compulsory Treatment
Compulsory Treatment of Alcohol and Drug Dependent Patients and Dual Diagnosis in 5 Counties of Health Region South-East, Norway
The Norwegian Social and Welfare Act of 1992, opened for compulsory commitment of patients with serious alcohol and drug problems to inpatient care. Clinical research of compulsory committed dual diagnosed patients is to date unavailable and is demanded by the health authorities of Norway. Because there has been limited examination/screening and no post-treatment research efforts on this group of patients, the investigators have limited knowledge of the treatment as well as the patient group. Do compulsory treated patients differ from those voluntarily admitted? Does this type of treatment influence the patients' motivation to change their behaviour, and does the treatment effort lead to positive outcome effects in the long run?
The primary aim is to acquire new and in depth descriptive knowledge about the compulsory treated group of patients according to: Drug dependence, psychiatric and somatic co-morbidity and socio-demographic characteristics, and investigate whether the treatment yields the intended outcomes in terms of improved substance abuse measures.
A second aim is to compare the group with a corresponding group of voluntarily admitted patients within the same wards. A follow-up interview focusing on motivational issues within 6 months post treatment to evaluate the long-term results of the treatment is planned.
A quasi-experimental, prospective case-control study will be conducted. Compulsory committed patients in five counties during a two year period, will be compared to a group of voluntarily admitted patients. The groups will be compared regarding 1) description and screening 2) motivation to change and 3) outcome results after 6 months.
Both official authorities as well as clinical practitioners would benefit from valid Norwegian results and knowledge within this field to form further policies and evidence based best practice for this vulnerable group of patients.
Studieoversikt
Status
Studietype
Registrering (Faktiske)
Kontakter og plasseringer
Studiesteder
-
-
Vest Agder
-
Kristiansand, Vest Agder, Norge, 4604
- Sorlandet hospital
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Prøvetakingsmetode
Studiepopulasjon
Beskrivelse
Inclusion Criteria:
- Patients with alcohol and substance use disorders
- Estimated premorbid IQ of 70 or higher
Exclusion Criteria:
- Active drug or alcohol abuse
Studieplan
Hvordan er studiet utformet?
Designdetaljer
Kohorter og intervensjoner
Gruppe / Kohort |
|---|
|
Involuntary patients
Compulsory treated patients according to the Norwegian Social and Welfare Act of 1992.
Most patients have dualdiagnosis.
|
|
Voluntary patients
Voluntary patients on the same wards.
Most patients have dual-diagnosis.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Substance use outcomes measured by Europ-ASI Quality of Life
Tidsramme: 6 months after discharge
|
6 months after discharge
|
Sekundære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Psychological distress (SCL-90-R)
Tidsramme: 6 months after discharge
|
6 months after discharge
|
Samarbeidspartnere og etterforskere
Sponsor
Etterforskere
- Studieleder: Øistein Kristensen, Sørlandet Sykehus HF
Publikasjoner og nyttige lenker
Generelle publikasjoner
- Opsal A, Kristensen O, Clausen T. Readiness to change among involuntarily and voluntarily admitted patients with substance use disorders. Subst Abuse Treat Prev Policy. 2019 Nov 6;14(1):47. doi: 10.1186/s13011-019-0237-y.
- Pasareanu AR, Vederhus JK, Opsal A, Kristensen O, Clausen T. Mental distress following inpatient substance use treatment, modified by substance use; comparing voluntary and compulsory admissions. BMC Health Serv Res. 2017 Jan 3;17(1):5. doi: 10.1186/s12913-016-1936-y.
Studierekorddatoer
Studer hoveddatoer
Studiestart
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Anslag)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Anslag)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- SSHF_815360
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .